Pharmacokinetics of topically applied ciprofloxacin in equine tears.

OBJECTIVE To evaluate the pharmacokinetics of topically applied ciprofloxacin 0.3% ophthalmic solution in tears of healthy horses. ANIMAL STUDIED Twenty healthy, adult, mixed-breed horses. PROCEDURES Twenty study horses were confirmed free of ophthalmic disease by complete ophthalmic examination. Seventy microliters of 0.3% ciprofloxacin (Ciloxan) was placed in the ventral cul-de-sac of each eye using a microliter syringe and 19-g cannula. Population kinetics were carried out by sampling the tear film from the lower cul-de-sac of each eye with tear test strips at 5, 10, 15 and 30 min and 1, 2, 4 and 6 h post administration for a total of five samples at each time-point. Sample collection time was 15 s. Concentrations of ciprofloxacin were determined using high performance liquid chromatography. RESULTS Mean (+/-SD) of the Schirmer tear test results from all eyes was 23.4 +/- 4.8 mm wetting in 1 min. Mean concentration of ciprofloxacin in the tears at 5 min post administration was 498.4 +/- 266.8 microg/g. Mean concentration rapidly declined and began to plateau at 30 min. The mean tear concentrations of ciprofloxacin at 30 min and at 1, 2, 4 and 6 h were 66.6 +/- 56.0, 60.25 +/- 55.7, 42.25 +/- 30.9, 36.25 +/- 32.0, and 45.5 +/- 46.5 microg/g, respectively. CONCLUSIONS The pharmacokinetics of ciprofloxacin in normal horses are similar to those in rabbits and humans. Topical application of ciprofloxacin resulted in a mean tear concentration of ciprofloxacin that remained above the MIC(90) levels for most pathogenic bacteria for 6 h post administration.

[1]  D. Hendrix,et al.  Bacterial isolates and antimicrobial susceptibilities in equine bacterial ulcerative keratitis (1993--2004). , 2010, Equine veterinary journal.

[2]  M. Nordlund,et al.  Concentrations of Levofloxacin, Ofloxacin, and Ciprofloxacin in Human Corneal Stromal Tissue and Aqueous Humor After Topical Administration , 2004, Cornea.

[3]  P. Sauer,et al.  Changes in antibiotic resistance in equine bacterial ulcerative keratitis (1991-2000): 65 horses. , 2003, Veterinary ophthalmology.

[4]  M. Raizman,et al.  Tear concentrations of levofloxacin following topical administration of a single dose of 0.5% levofloxacin ophthalmic solution in healthy volunteers. , 2002, Clinical therapeutics.

[5]  M. Trousdale,et al.  In Vitro Susceptibilities of Bacterial Ocular Isolates to Fluoroquinolones , 2001, Cornea.

[6]  D. Tang-Liu,et al.  Comparison of tear sampling techniques for pharmacokinetics analysis: ofloxacin concentrations in rabbit tears after sampling with schirmer tear strips, capillary tubes, or surgical sponges. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[7]  C. Felix,et al.  In Vitro Antibiotic Susceptibilities of Ocular Isolates in North and South America , 1998 .

[8]  A. Akkan,et al.  Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes. , 1997, International journal of clinical pharmacology and therapeutics.

[9]  R. Snyder,et al.  Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin. , 1997, Archives of ophthalmology.

[10]  Y. Shimomura,et al.  Pharmacokinetics of topically applied ciprofloxacin in rabbit tears. , 1996, Japanese journal of ophthalmology.

[11]  J. Diamond,et al.  Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration. , 1995, The British journal of ophthalmology.

[12]  F. Price,et al.  Corneal Tissue Levels of Topically Applied Ciprofloxacin , 1995, Cornea.

[13]  C. Buggé,et al.  Tear Concentrations of Topically Applied Ciprofloxacin , 1994, Cornea.

[14]  J. Cowden,et al.  Corneal stromal penetration of topical ciprofloxacin in humans. , 1993, Ophthalmology.

[15]  E. Lin,et al.  Ofloxacin in Human Serum, Urine, and Tear Film After Topical Application , 1992, Cornea.

[16]  D. Tang-Liu,et al.  Comparison of ofloxacin, gentamicin, and tobramycin concentrations in tears and in vitro MICs for 90% of test organisms , 1990, Antimicrobial Agents and Chemotherapy.

[17]  J. Prescott,et al.  In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. , 1990, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[18]  M. L. Gilbert,et al.  Comparative bioavailability and efficacy of fortified topical tobramycin. , 1987, Investigative ophthalmology & visual science.